ONWARD MEDICAL (ONWD.BR) Stock Income Statement
EBR:ONWD - Euronext Brussels - NL0015000HT4 - Common Stock - Currency: EUR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 68.00K | 104.00K | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 35.43M | 35.53M | 32.13M | 28.53M | 15.51M | |||
| Research and Development | 17.76M | 18.75M | 18.89M | 15.39M | 9.51M | |||
| Selling, General, and Administrative Expenses | 16.38M | 15.38M | 13.41M | 13.18M | 5.63M | |||
| Operating Income | -35.43M | -35.46M | -32.03M | -28.53M | -15.51M | |||
| Interest Income/Expense | 25.00K | -594.00K | -1.48M | -5.70M | -4.47M | |||
| Other Income/Expense | N/A | -17.00K | -33.00K | -16.00K | -12.00K | |||
| Income Before Taxes | -35.41M | -36.07M | -33.54M | -34.24M | -19.99M | |||
| Income Tax | -256.00K | 107.00K | -766.00K | 69.00K | 20.00K | |||
| Net Income | -35.15M | -36.18M | -32.77M | -34.31M | -20.01M | |||
| EBITDA | -34.60M | -34.74M | -31.29M | -28.20M | -15.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.09 | -1.20 | -1.09 | -3.62 | -0.67 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -53207.35% | -31511.54% | N/A | N/A | |||
| Operating Profit Margin | N/A | -52151.47% | -30796.15% | N/A | N/A | |||
All data in EUR